Newer herbal treatment modality for management of Lichen Planus

Comparison of Topical Purslane & topical 0.1% triamcinolone acetonide in the management of Oral Lichen Planus - A double blinded clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/09/036647

Enrollment

Registered

2021-09-20

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are willing to participate in the study. Patients with symptomatic (burning sensation or pain) reticular type oral lichen planus and who had not under gone any previous treatment for the same in the last six months. Clinically and histopathologically confirmed Oral lichen Planus. Patients with other systemic diseases ( Diaebtes & hypertension) & those not under any long term glucocorticosteroid therapy.

Exclusion criteria

Exclusion criteria: Histopathologically proven lichenoid reaction. Patients with other white lesions like leukoplakia, systemic lupus erythematosus(SLE) along with oral lichen planus. Patients with other systemic diseases & those on long term glucocorticosteroid therapy. Patients having extra oral manifestations of oral lichen planus during the duration of treatment. Pregnancy, lactation. History of allergic reactions to herbal preparations.

Design outcomes

Primary

Measure	Time frame
Alllieviatiom of burning sensationTimepoint: Baseline, 2nd week,1st,2nd & 3rd month	—

Secondary

Measure	Time frame
Relief of symptomsTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Arul Jothi Murugan

SRM DENTAL COLLEGE

anug77@yahoo.com9962099944

Outcome results